for Investors
for Partners
for Media
Main contents starts here
What's New
- July 16, 2008
Antiosteoporotic drugs “Actonel® 17.5 mg tablets” and “Benet® 17.5 mg tablets” received approval for additional indication in patients with Paget’s disease of bone: Both come in new packages. - July 14, 2008
Notice Concerning the Determination of the Items of Stock Options (Stock Acquisition Rights) for Members of the Board of Directors - July 8, 2008
Takeda Submitted a Request for Mutual Agreement Procedure Regarding a Correction Notice Based on Transfer Pricing Taxation
Topics
- July 31, 2008
1st Quarter of FY2008 financial results announcement & conference call
Stock Performance
TSE 7/25 15:00
- Last
- 5,440
- Change
- -90
